4th International Bladder Cancer Update

Virtual CME Symposium

April 28, 2021 | 6:00pm-10:00pm EDT (starting at 5pm CT/4pm MT/3pm PT)

Program Access

Access sessions by clicking on the green “Join Now” button(s).

UTM Builder

Wednesday, April 28, 2021 (All times EDT)

6:00pm-6:10pm

Introduction
Program Co-Directors: Michael S. Cookson, MD, MMHC and Daniel P. Petrylak, MD

JOIN NOW

6:05pm-6:25pm

AUA/SUO/ASTRO MIBC Guidelines Review
Michael S. Cookson, MD, MMHC

6:25pm-6:35pm

Urine Biomarkers for the Detection of Urothelial Carcinoma
Siamak Daneshmand, MD

6:35pm-6:50pm

Panel Discussion on Cxbladder Genomic Urine Test for Bladder Cancer (non-CME)
Moderator: Siamak Daneshmand, MD
Discussants: Sima P. Porten, MD, and Anne K. Shuckman, MD

6:50pm-7:00pm

Overview of Available Treatment Options in Metastatic Bladder Cancer
Daniel P. Petrylak, MD

7:00pm-7:45pm

Spotlight Lecture/Product Theater (non-CME)
A Treatment Approach for Certain Patients with High-Risk Non-Muscle Invasive Bladder Cancer
Speaker: Neal D. Shore, MD
Supported by Merck

JOIN NOW

7:45pm-8:00pm

Continuation of Update on Available Treatment Options in Metastatic Bladder Cancer
Daniel P. Petrylak, MD

JOIN NOW

8:00pm-8:15pm

Lecture on Blue Light vs. White Light Cystoscopy
Sanjay Patel, MD

8:15pm-8:30pm

Panel Discussion on Gene Therapy for BCG-Unresponsive Patients (live)
Moderator: Daniel P. Petrylak, MD
Discussants: Colin P. Dinney, MD, Petros Grivas, MD, PhD, and Seth P. Lerner, MD

8:30pm-9:15pm

Spotlight Lecture/Product Theater (non-CME)
The Role of Genetic Alterations and Treatment of Patients With Locally Advanced or Metastatic Urothelial Carcinoma (mUC)
Speaker: Gordon Brown, DO, FACOS
Supported by Janssen Biotech

JOIN NOW

9:15pm-9:30pm

Updates in Upper Tract Urothelial Cancer
Seth P. Lerner, MD

JOIN NOW

9:30pm-10:00pm

Spotlight Lecture/Product Theater (non-CME)
Expanding Kidney-Sparing Options for Patients with Low-Grade Upper Tract Urothelial Cancer
Speaker: Jennifer A. Linehan, MD
Supported by UroGen Pharma

10:00pm

Concluding Remarks and Adjourn
Daniel P. Petrylak, MD

Symposium Access

Access sessions by clicking on the green “Join Now” button(s).

Wednesday, April 28, 2021 (All times EDT)

6:00pm-7:00pm Session

JOIN NOW

6:00pm-6:10pm
Introduction
Program Co-Directors: Michael S. Cookson, MD, MMHC and Daniel P. Petrylak, MD

6:05pm-6:25pm
AUA/SUO/ASTRO MIBC Guidelines Review
Michael S. Cookson, MD, MMHC

6:25pm-6:35pm
Urine Biomarkers for the Detection of Urothelial Carcinoma
Siamak Daneshmand, MD

6:35pm-6:50pm
Panel Discussion on Cxbladder Genomic Urine Test for Bladder Cancer (non-CME)
Moderator: Siamak Daneshmand, MD
Discussants: Sima P. Porten, MD, and Anne K. Shuckman, MD

6:50pm-7:00pm
Overview of Available Treatment Options in Metastatic Bladder Cancer
Daniel P. Petrylak, MD

7:00pm-7:45pm Session (non-CME)

JOIN NOW

Spotlight Lecture/Product Theater (non-CME)
A Treatment Approach for Certain Patients with High-Risk Non-Muscle Invasive Bladder Cancer
Speaker: Neal D. Shore, MD
Supported by Merck

7:45pm-8:30pm Session

JOIN NOW

7:45pm-8:00pm
Continuation of Update on Available Treatment Options in Metastatic Bladder Cancer
Daniel P. Petrylak, MD

8:00pm-8:15pm
Lecture on Blue Light vs. White Light Cystoscopy
Sanjay Patel, MD

8:15pm-8:30pm
Panel Discussion on Gene Therapy for BCG-Unresponsive Patients (live)
Moderator: Daniel P. Petrylak, MD
Discussants: Colin P. Dinney, MD, Petros Grivas, MD, PhD, and Seth P. Lerner, MD

8:30pm-9:15pm Session (non-CME)

JOIN NOW

Spotlight Lecture/Product Theater (non-CME)
The Role of the First FDA-Approved Kinase Inhibitor of FGFR3 or 2
Genetic Alterations for the Treatment of Locally Advanced or
Metastatic Urothelial Carcinoma (mUC) in Patients Who Have Received Prior Platinum-Based Therapy
Speaker: Gordon Brown, DO, FACOS
Supported by Janssen Biotech

9:15pm-10:00pm Session

JOIN NOW

9:15pm-9:30pm
Updates in Upper Tract Urothelial Cancer
Seth P. Lerner, MD

9:30pm-10:00pm
Spotlight Lecture/Product Theater (non-CME)
Expanding Kidney-Sparing Options for Patients with Low-Grade Upper Tract Urothelial Cancer
Speaker: Jennifer A. Linehan, MD
Supported by UroGen Pharma

10:00pm
Concluding Remarks and Adjourn
Daniel P. Petrylak, MD

Meeting organized by Grand Rounds in Urology, a division of Carden Jennings Publishing, Co., Ltd.

Jointly provided by Medical Education Resources and Carden Jennings Publishing Co., Ltd.